Permanent hair dyes and bladder cancer: Risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2

Carcinogenesis

Volumn 24, Issue 3, 2003, Pages 483-489

  Gago Dominguez, Manuela ^a   Bell, Douglas A ^a   Watson, Mary A ^b   Yuan, Jian Min ^a   Castelao, J Esteban ^a   Hein, David W ^c   Chan, Kenneth K ^d   Coetzee, Gerhard A ^a   Ross, Ronald K ^a   Yu, Mimi C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c University of Louisville School of Medicine   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 1A2; GLUTATHIONE TRANSFERASE; HAIR DYE;

ACETYLATOR PHENOTYPE; ADULT; BLADDER CANCER; BLADDER CARCINOGENESIS; CANCER RISK; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FREQUENCY ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE;

ADULT; ARYLAMINE N-ACETYLTRANSFERASE; CYTOCHROME P-450 CYP1A2; FEMALE; GENOTYPE; HAIR DYES; HUMANS; ISOENZYMES; MIDDLE AGED; PHENOTYPE; URINARY BLADDER NEOPLASMS;

EID: 0037356860     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/24.3.483     Document Type: Review

References (51)

1. Gago-Dominguez,M., Castelao,J.E., Yuan,J.-M., Yu,M.C. and Ross,R.K. (2001) Use of permanent hair dyes and bladder cancer risk. Int. J. Cancer, 91, 575-579.
2. Gago-Dominguez,M., Chan,K.K., Ross,R.K. and Yu,M.C. (2001) Permanent hair dyes and bladder cancer risk. Int. J. Cancer, 94, 905-906.
3. Kadlubar,F.F., Fu,P.P., Jung,H., Shaikh,A.U. and Beland,F.A. (1990) The metabolic N-oxidation of carcinogenic arylamines in relation to nitrogen charge density and oxidation potential. Environ. Health Perspect., 87, 233-236.
4. Hammons,G.J., Guengerich,F.P., Weis,C.C., Beland,F.A. and Kadlubar,F.F. (1985) Metabolic oxidation of carcinogenic arylamines by rat, dog and human hepatic microsomes and by purified flavin-containing and cytochrome P-450 monooxygenases. Cancer Res., 45, 3578-3585.
5. Butler,M.A., Guengerich,F.P. and Kadlubar,F.F. (1989) Metabolic oxidation of the carcinogens 4-aminobiphenyl and 4,4′-methylene-bis (2-chloroaniline) by human hepatic microsomes and by purified rat hepatic cytochrome P-450 monooxygenases. Cancer Res., 49, 25-31.
6. Turesky,R.J., Fay,L.B. and Welti,D.H. (1995) Metabolism of heterocyclic aromatic amines and strategies of human biomonitoring. Princess Takamatsu Symp., 23, 59-68.
7. Hein,D.W., Doll,M.A., Fretland,A.J., et al. (2000) Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol. Biomarkers Prev., 9, 29-42.
8. Kawakubo,Y., Merk,H.F., Masaoudi,T.A., Sieben,S. and Blomeke,B. (2000) N-acetylation of paraphenylenediamine in human skin and keratinocytes. J. Pharmacol. Exp. Ther., 292, 150-155.
9. Reilly,T.P., Lash,L.H., Doll,M.A., Hein,D.W., Woster,P.M. and Svensson,C.K. (2000) A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J. Invest. Dermatol., 114, 1164-1173.
10. Kadlubar,F.F. and Badawi,A.F. (1995) Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis. Toxicol. Lett., 82-83, 627-632.
11. Kirlin,W.G., Trinidad,A., Yerokun,T., et al. (1989) Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol. Cancer Res., 49, 2448-2454.
12. Frederickson,S.M., Messing,E.M., Reznikoff,C.A. and Swaminathan,S. (1994) Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells. Cancer Epidemiol. Biomarkers Prev., 3, 25-32.
13. Badawi,A.F., Hirvonen,A., Bell,D.A., Lang,N.P. and Kadlubar,F.F. (1995) Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res., 55, 5230-5237.
14. Hayes,J.D. and Pulford,D.J. (1995) The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol., 30, 445-600.
15. Bernstein,L. and Ross,R.K. (1991) Cancer in Los Angeles County. A Portrait of Incidence and Mortality 1972-1987. University of Southern California, Los Angeles, CA.
16. Bell,D.A., Taylor,J.A., Paulson,D.F., Robertson,C.N., Mohler,J.L. and Lucier,G.W. (1993) Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl Cancer Inst., 85, 1159-1164.
17. Arand,M., Muhlbauer,R., Hengstler,J., Jager,E., Fuchs,J., Winkler,L. and Oesch,F. (1996) A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S-transferase GSTM1 and GSTT1 polymorphisms. Anal. Biochem., 236, 184-186.
18. Harries,L.W., Stubbins,M.J., Forman,D., Howard,G.C.W. and Wolf,C.R. (1997) Identification of genetic polymorphisms at the glutathione S-transferase pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis, 18, 641-644.
19. Bell,D.A., Stephens,E.A., Castriano,T., et al. (1995) Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer. Cancer Res., 55, 3537-3542.
20. Taylor,J.A., Umbach,D.M., Stephens,E., Castriano,T., Paulson,D., Robertson,C., Mohler,J.L. and Bell,D.A. (1998) The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene exposure three-way interaction. Cancer Res., 58, 3603-3610.
21. Lin,H.J., Probst-Hensch,N.M., Hughes,N.C., et al. (1998) Variants of N-acetyltransferase NAT1 and a case-control study of colorectal adenomas. Pharmacogenetics, 8, 269-281.
22. Kalow,W. and Tang,B.K. (1991) Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities. Clin. Pharmacol. Ther., 50, 508-519.
23. Yu,M.C., Skipper,P.L., Taghizadeh,K., Tannenbaum,S.R., Chan,K.K., Henderson,B.E. and Ross,R.K. (1994) Acetylator phenotype, amino-biphenyl-hemoglobin adduct levels and bladder cancer risk in white, black and Asian men in Los Angeles, California. J. Natl Cancer Inst., 86, 712-716.
24. Breslow,N.E. and Day,N.E. (1980) Statistical Methods in Cancer Research, Volume I: The Analysis of Case-control Studies. IARC Scientific Publications No. 32. IARC, Lyon.
25. Castelao,J.E., Yuan,J.M., Skipper,P.L., et al. (2001) Gender- and smoking-related bladder cancer risk. J. Natl Cancer Inst., 93, 538-545.
26. Castelao,J.E., Yuan,J.-M., Gago-Dominguez,M., Yu,M.C. and Ross,R.K. (2000) Non-steroidal anti-inflammatory drugs and bladder cancer prevention. Br. J. Cancer, 82, 1364-1369.
27. Probst-Hensch,N.M., Tannenbaum,S.R., Chan,K.K., Coetzee,G.A., Ross,R.K. and Yu,M.C. (1998) Absence of the glutathione S-transferase M1 gene increases cytochrome P4501A2 activity among frequent consumers of cruciferous vegetables in a Caucasian population. Cancer Epidemiol. Biomarkers Prev., 7, 635-638.
28. Jefferson,F., Xiao,G. and Hein,D.W. (2002) NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amines in primary mammary epithelial cell cultures from rapid and slow acetylator rats. Toxicol. Sci.., 66 (1-S), LB148.
29. Cascorbi,I., Roots,I. and Brockmoller,J. (2001) Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10. Cancer Res., 61, 5051-5056.
30. Milman,H.A. and Peterson,C. (1984) Apparent correlation between structure and carcinogenicity of phenylenediamines and related compounds. Environ. Health Perspect., 56, 261-273.
31. Kadlubar,F.F. and Hammons,G.J. (1986) The role of cytochrome P-450 in the metabolism of chemical carcinogens. In Guengerich, FP (ed.) Mammalian Cytochromes P-450, Vol II. CRC Press, Boca Raton, FL, pp. 81-130.
32. Kawakubo,Y., Manabe,S., Yamazoe,Y., Nishikawa,T. and Kato,R. (1988) Properties of cutaneous acetyltransferase catalyzing N- and O-acetylation of carcinogenic arylamines and N-hydroxyarylamine. Biochem. Pharmacol., 37, 265-270.
33. Hein,D.W., McQueen,C.A., Grant,D.M., Goodfellow,G.H., Kadlubar,F.F. and Weber,W.W. (2000) Pharmacogenetics of the arylamine N-acetyltransferases: a symposium in honor of Wendell W. Weber. Drug Metab. Dispos., 28, 1425-1432.
34. Hsu,T.S., Davis,M.D., el-Azhary,R., Corbett,J.F. and Gibson,L.E. (2001) Beard dermatitis due to para-phenylenediamine use in Arabic men. J. Am. Acad. Dermatol., 44, 867-869.
35. Corbett,J.F. and Menkart,J. (1973) Hair coloring. Cutis, 12, 190-197.
36. Wiese,F.W., Thompson,P.A. and Kadlubar,F.F. (2001) Carcinogen substrate specificity of human COX-1 and COX-2. Carcinogenesis, 22, 5-10.
37. Flammang,T.J., Yamazoe,Y., Benson,R.W., Roberts,D.W., Potter,D.W., Chu,D.Z., Lang,N.P. and Kadlubar,F.F. (1989) Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes. Cancer Res., 49, 1977-1982.
38. Park,J.M., Yang,T., Arend,L.J., Smart,A.M., Schnermann,J.B. and Briggs,J.P. (1997) Cyclooxygenase-2 is expressed in bladder during fetal development and stimulated by outlet obstruction. Am. J. Physiol., 273, F538-544.
39. Wheeler,M.A., Hausladen,D.A., Yoon,J.H. and Weiss,R.M. (2002) Prostaglandin E2 production and cyclooxygenase-2 induction in human urinary tract infections and bladder cancer. J. Urol., 168, 1568-1573.
40. Bull,A.W. (1984) Reducing substrate activity of some aromatic amines for prostaglandin H synthase. Carcinogenesis, 8, 387-390.
41. Nordenskjold,M., Andersson,B., Rahimtula,A. and Moldeus,P. (1984) Prostaglandin synthase-catalyzed metabolic activation of some aromatic amines to genotoxic products. Mutat. Res., 127, 107-112.
42. Robertson,I.G., Sivarajah,K., Eling,T.E. and Zeiger,E. (1983) Activation of some aromatic amines to mutagenic products by prostaglandin endoperoxide synthetase. Cancer Res., 43, 476-480.
43. Hartge,P., Hoover,R., Altman,R., et al. (1982) Use of hair dyes and risk of bladder cancer. Cancer Res., 42, 4784-4787.
44. Claude,J., Kunze,E., Frentzel-Beyme,R., Paczkowski,K., Schneider,J. and Schubert,H. (1986) Life-style and occupational risk factors in cancer of the lower urinary tract. Am. J. Epidemiol., 124, 578-589.
45. Howe,G.R., Burch,J.D., Miller,A.B., et al. (1980) Tobacco use, occupation, coffee, various nutrients and bladder cancer. J. Natl Cancer Inst., 64, 701-713.
46. Nomura,A., Kolonel,L.N. and Yoshizawa,C.N. (1989) Smoking, alcohol, occupation and hair dye use in cancer of the lower urinary tract. Am. J. Epidemiol., 130, 1159-1163.
47. Ohno,Y., Aoki,K., Obata,K. and Morrison,A.S. (1985) Case-control study of urinary bladder cancer in metropolitan Nagoya. Natl Cancer Inst. Monogr., 69, 229-234.
48. Sullivan,J.W. (1982) Epidemiologic survey of bladder cancer in greater New Orleans. J. Urol., 128, 281-283.
49. Hennekens,C.H., Speizer,F.E., Rosner,B., Bain,C.J., Belanger,C. and Peto,R. (1979) Use of permanent hair dyes and cancer among registered nurses. Lancet, 1, 1390-1393.
50. Henley,S.J. and Thun,M.J. (2001) Use of permanent hair dyes and bladder-cancer risk. Int. J. Cancer, 94, 903-904.
51. Wingo,P.A., Tong,T. and Bolden,S. (1995) Cancer statistics, 1995. Cancer J. Clin., 45, 8-30.